Non-pharmaceutical interventions taken by China during the prevention and control of COVID-19

Author:

Yuan Zhiling

Abstract

To study and analyze the effective non-pharmaceutical interventions taken by China during the avoidance and management of COVID-19, in order to provide suggestions for future response to major public health emergencies. Search for keywords such as 'COVID-19', 'SARS-CoV-2', 'non-pharmaceutical interventions', and 'control strategies' on PubMed, and establish domestic and foreign literature as well as dynamic epidemic reports and expert comments issued by official institutions and summary. During the epidemic, traditional infectious disease prevention measures were adopted, such as isolation, case testing, personal protection (wearing masks), and new measures, such as expanding social distance and restricting travel. Through the precise implementation of prevention and control measures, most Asian countries, mainly China, have effectively controlled the spread of the new coronavirus in the first half of 2020. Studies have shown that measures taken during the epidemic have reduced the spread of the new coronavirus and the incidence of other respiratory infectious illnesses. For the outbreak center of the epidemic, taking Wuhan as an example, targeted prevention and control measures such as closing schools, closing cities, and establishing sheltered hospitals have been adopted, and these measures have achieved remarkable results. Only by doing so can we minimize the virus spread and curb the spread of the epidemic.

Publisher

Darcy & Roy Press Co. Ltd.

Reference41 articles.

1. The First Level Response Situation Analysis and Risk Assessment Team of the Novel Coronavirus Pneumonia Epidemic of the Chinese Center for Disease Control and Prevention. 2019 Novel Coronavirus Outbreak Progress and Risk Assessment [R]. Beijing: Chinese Center for Disease Control and Prevention, 2020.

2. SANCHE S, LIN Y T, XU C G, et al. The novel coronavirus, 2019 nCoV, is highly contagious and more infectious than initially estimated [EB/OL]. (2020-02-11) [2020-03-17]. https://www.medrxiv.org/ content/10.1101/2020.02.07.20021154v1.

3. SHENG Z, DIAO M Y, YU W B, et al. Estimation of the reproductive number of Novel Coronavirus (COVID -19) and the probable outbreak size on the Diamond Princess cruise ship: a datadriven analysis [J/OL]. Intern J Infect Dis (2020 -02 -22) [2020-03-17]. https://doi.org/10.1016/j.ijid.2020.02.033.

4. World Health Organization. Weekly epidemiological update-19 January 2021 [EB/OL]. (2021-01-19) [2021-03-02]. https://www.who.int/publications/m/item/weekly-epidemiological-update---19-january-2021.

5. Lin Junfen, Wu Mengna, Wu Haocheng, et al. Epidemiological characteristics of cases of novel coronavirus pneumonia in Zhejiang Province [J]. Preventive Medicine, 2020, 32(3): 217-221, 225.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3